Daiichi Sankyo Co Ltd - Company & Market Research Reports

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.


Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets - Product Thumbnail Image

Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets

  • Report
  • 126 Pages
From
World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections) - Product Thumbnail Image

World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections)

  • Report
  • 220 Pages
From
Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017

  • Report
  • 79 Pages
From
The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment - Product Thumbnail Image

The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment

  • Report
  • 320 Pages
From
Diabetic Macular Edema - Pipeline Review, H1 2018 - Product Thumbnail Image

Diabetic Macular Edema - Pipeline Review, H1 2018

  • Report
  • 209 Pages
From
The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis - Product Thumbnail Image

The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis

  • Report
  • 104 Pages
From
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • Report
  • 148 Pages
From
India Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Thumbnail Image

India Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Report
  • 143 Pages
From
Japan Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Thumbnail Image

Japan Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Report
  • 122 Pages
From
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update

  • Report
  • 462 Pages
From
Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies - 2016 Update

  • Report
  • 124 Pages
From
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2018

  • Report
  • 50 Pages
From
Diabetic Nephropathy Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Diabetic Nephropathy Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 317 Pages
From
Dermatitis - Pipeline Review, H1 2015 - Product Thumbnail Image

Dermatitis - Pipeline Review, H1 2015

  • Report
  • 381 Pages
From
Japan In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture - Product Thumbnail Image

Japan In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

  • Report
  • 511 Pages
From
Drug Overview: Prolia - Product Thumbnail Image

Drug Overview: Prolia

  • Report
  • 16 Pages
From
Osteoporosis - Pipeline Review, H1 2018 - Product Thumbnail Image

Osteoporosis - Pipeline Review, H1 2018

  • Report
  • 251 Pages
From
Diabetic Neuropathic Pain - Pipeline Review, H2 2016 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Review, H2 2016

  • Report
  • 95 Pages
From
Diabetic Neuropathic Pain - Pipeline Review, H1 2016 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Review, H1 2016

  • Report
  • 100 Pages
From
Loading Indicator
adroll